期刊
NATURE IMMUNOLOGY
卷 20, 期 4, 页码 397-+出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41590-019-0313-5
关键词
-
类别
资金
- Israel Science Foundation (ISF) [1416/15, 818/18]
- alpha-1 Foundation
- Recanati Foundation (Tel Aviv University)
- Varda and Boaz Dotan Research Center
- National Health and Medical Research Council (NHMRC) of Australia [1037321, 1105209, 1080321, 1143976]
- NHMRC [1101405, 1145788, 1141466]
- National Health and Medical Research Council of Australia [1101405, 1105209, 1141466, 1145788, 1143976] Funding Source: NHMRC
Inflammasomes are one of the most important mechanisms for innate immune defense against microbial infection but are also known to drive various inflammatory disorders via processing and release of the cytokine IL-1 beta. As research into the regulation and effects of inflammasomes in disease has rapidly expanded, a variety of cell types, including dendritic cells (DCs), have been suggested to be inflammasome competent. Here we describe a major fault in the widely used DC-inflammasome model of bone marrow-derived dendritic cells (BMDCs) generated with the cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF). We found that among GM-CSF bone marrow-derived cell populations, monocyte-derived macrophages, rather than BMDCs, were responsible for inflammasome activation and IL-1 beta secretion. Therefore, GM-CSF bone marrow-derived cells should not be used to draw conclusions about DC-dependent inflammasome biology, although they remain a useful tool for analysis of inflammasome responses in monocytes-macrophages.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据